We are writing to you urgently concerning the announcement that the FDA has granted an Emergency Use Authorisation for both Pfizer and Moderna Covid-19 vaccines in preschool children.
A new study has been published in the peer-reviewed journal Andrology, reporting on pre- and post-vaccination sperm counts and quality in 37 sperm donors in Israel. There have long been concerns about the potential for the mRNA products to have deleterious effects on male fertility, particularly after frequent reports of female menstrual irregularities, and the (now widely accepted) confirmation that the Lipid-nanoparticles become distributed around the body.
There was never any reason to expect that “natural immunity” – the protection acquired through infection to SARS-COV-2 – should not be similar to that acquired for other respiratory viruses humankind has come into contact with – robust, flexible and durable. Were it not, our species would have been wiped out many millennia ago.
Whether this is Omicron or cross reactivity with previously endemic coronaviruses is uncertain. What is clear from the Ct values in the ONS Infection Survey is that neither “non-pharmaceutical interventions” or vaccines have had any impact on waves of infectious SARS-CoV-2 carriers and that neither economically destructive lockdowns or mandating experimental vaccines should ever have been attempted.
The ONS have published their survey data on the number of working aged people who are economically inactive. The levels are higher than in the past and many commentators were quick to blame the rise on long covid. It is worth looking a little more closely before jumping to that conclusion.
From late 2020, the various harms of lockdowns, particularly for children, were becoming apparent, with acknowledgement from the DfE and OFSTED that all was not well. Signs of deterioration in adolescent mental health and increase in domestic violence and child abuse were noted, as summarised by the HART team.
The FDA met on 15th June and despite all the evidence of non-efficacy from the infant Pfizer vaccine and the still total lack of data on long-term harms, they went ahead. If the last eighteen months are anything to go by, the MHRA will follow soon, followed after a respectable few weeks by the JCVI. Indeed, vaccination for this age-group is already listed for JCVI discussion.
Last week we published Part 2 of our evidence updates, focusing on ethics, masks and elderly care. This week, we take another detailed look at the collateral damage caused by lockdowns and rather topically have reworked the piece on covid vaccines for children.
There has been a vast quantity of water under the bridge since this article first appeared in March 2021 as part of HART’s COVID-19: an overview of the evidence. Despite numerous unanswered questions to the regulators, and legal challenges, the ethical and legal precept of protecting children was dropped in the clamour to protect society as a whole.
A texan court ordered that the FDA release the documents used by the FDA to give emergency use authorisation for the Pfizer vaccine. The FDA asked if these documents could be kept hidden until 2076 but by August all will have been shared. Early analysis has demonstrated several concerning anomalies but crucially it has revealed that the efficacy data was not what was sold.
We are a group of health professionals and scientists from the UK, who submitted a letter to the FDA meeting in March regarding our concerns over the potential authorisation of Pfizer vaccine for children aged 6 months to 4 years and our letter is reattached today in readiness for your June meeting. No new evidence has come to light since our March letter, which gives any credibility to the necessity, safety or even efficacy of this vaccine for infants.
On the 1st of June 2022, NHS England issued further guidance regarding the use of face masks in clinical settings. In what could be – optimistically – construed as further progress towards the Government’s ‘Living with covid’ goal, this latest official briefing directs hospitals and other care settings to end the requirement for staff, patients and visitors to wear face coverings in most wards and departments.
In March 2021, we wrote two sections in ‘Covid-19 the evidence’, namely ‘Economic impacts – the true cost of lockdown’ and ‘Lockdowns – do they work?’. Over a year later, we have revisited not only the financial costs of lockdowns but also the societal costs, the impact on healthcare and the lack of evidence for overall benefit.
When the JCVI considered covid vaccines for children in July 2021, they stated, “JCVI is of the view that the health benefits of universal vaccination in children and young people below the age of 18 years do not outweigh the potential risks.
The official narrative claims that vaccines prevent infection and therefore reduce risk of myocarditis from infection. This claim is reliant on two points: 1. Vaccines reducing infections 2. That infection related myocarditis occurs at a lower rate in the vaccinated.
Last week we published our first 3 evidence updates, focusing on aspects of the SARS-CoV-2 virus itself, its variants and natural immunity, with implications for border closures and futile attempts at achieving ‘zero covid’.